Zobrazeno 1 - 4
of 4
pro vyhledávání: '"NJ Dollekamp"'
Autor:
F. Vandaele, José Belderbos, Hugo Vrenken, M. van Herk, E. Lamers, J.C. de Munck, NJ Dollekamp, Sanne B. Schagen, Yolande Lievens, F. Bartel, Stefan Sunaert, Dirk De Ruysscher, Emt Dieleman, K. De Jaeger, C. Carbaat, M.B. de Ruiter
Publikováno v:
Clinical and Translational Oncology, 21(2), 178-186. Springer-Verlag Italia
Clinical & translational oncology, 21(2), 178-186. SPRINGER-VERLAG ITALIA SRL
Bartel, F, van Herk, M, Vrenken, H, Vandaele, F, Sunaert, S, de Jaeger, K, Dollekamp, N J, Carbaat, C, Lamers, E, Dieleman, E M T, Lievens, Y, de Ruysscher, D, Schagen, S B, de Ruiter, M B, de Munck, J C & Belderbos, J 2019, ' Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation ', Clinical and Translational Oncology, vol. 21, no. 2, pp. 178-186 . https://doi.org/10.1007/s12094-018-1903-7
Clinical & translational oncology, 21(2), 178-186. Springer-Verlag Italia
Bartel, F, Van Herk, M, Vrenken, H, Vandaele, F, Sunaert, S, De Jaeger, K, Dollekamp, N J, Carbaat, C, Lamers, E, Dieleman, E M T, Lievens, Y, De Ruysscher, D, Schagen, S B, De Ruiter, M B, De Munck, J C & Belderbos, J 2018, ' Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation ', Clinical and Translational Oncology . https://doi.org/10.1007/s12094-018-1903-7
Clinical & Translational Oncology, 21(2), 178-186. Springer
Clinical & translational oncology, 21(2), 178-186. SPRINGER-VERLAG ITALIA SRL
Bartel, F, van Herk, M, Vrenken, H, Vandaele, F, Sunaert, S, de Jaeger, K, Dollekamp, N J, Carbaat, C, Lamers, E, Dieleman, E M T, Lievens, Y, de Ruysscher, D, Schagen, S B, de Ruiter, M B, de Munck, J C & Belderbos, J 2019, ' Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation ', Clinical and Translational Oncology, vol. 21, no. 2, pp. 178-186 . https://doi.org/10.1007/s12094-018-1903-7
Clinical & translational oncology, 21(2), 178-186. Springer-Verlag Italia
Bartel, F, Van Herk, M, Vrenken, H, Vandaele, F, Sunaert, S, De Jaeger, K, Dollekamp, N J, Carbaat, C, Lamers, E, Dieleman, E M T, Lievens, Y, De Ruysscher, D, Schagen, S B, De Ruiter, M B, De Munck, J C & Belderbos, J 2018, ' Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation ', Clinical and Translational Oncology . https://doi.org/10.1007/s12094-018-1903-7
Clinical & Translational Oncology, 21(2), 178-186. Springer
BackgroundHippocampal avoidance prophylactic cranial irradiation (HA-PCI) techniques have been developed to reduce radiation damage to the hippocampus. An inter-observer hippocampus delineation analysis was performed and the influence of the delineat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faf1547f1d545934e57eb452273e1970
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85048042870&origin=inward
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85048042870&origin=inward
Autor:
Yolande Lievens, E. Dieleman, José Belderbos, M. van Herk, F. Vandaele, J.C. de Munck, K. De Jaeger, Hugo Vrenken, Stefan Sunaert, Sanne B. Schagen, E. Lamers, Dirk De Ruysscher, C. Carbaat, M.B. de Ruiter, NJ Dollekamp, F. Bartel
Publikováno v:
Radiotherapy and Oncology. 127:S384-S385
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1c8d5d01a81ef955c7ea78c2f1af8ce
https://doi.org/10.1016/s0167-8140(18)31058-2
https://doi.org/10.1016/s0167-8140(18)31058-2
Autor:
Bartel F; Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands., van Herk M; Department of Cancer Sciences, University of Manchester, Manchester, UK., Vrenken H; Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands., Vandaele F; Department of Radiotherapy, Iridium Cancer Network, Antwerp, Belgium., Sunaert S; Department of Radiology, University Hospitals Leuven, Louvain, Belgium., de Jaeger K; Department of Radiotherapy, Catharina Hospital, Eindhoven, The Netherlands., Dollekamp NJ; Department of Radiotherapy, The University Medical Center Groningen, Groningen, The Netherlands., Carbaat C; Department of Radiotherapy, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Lamers E; Department of Radiotherapy, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Dieleman EMT; Department of Radiotherapy, Academic Medical Center, Amsterdam, The Netherlands., Lievens Y; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium., de Ruysscher D; Department of Radiotherapy, Maastricht University Medical Center, Maastricht, The Netherlands., Schagen SB; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Ruiter MB; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Munck JC; Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands., Belderbos J; Department of Radiotherapy, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. j.belderbos@nki.nl.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2019 Feb; Vol. 21 (2), pp. 178-186. Date of Electronic Publication: 2018 Jun 06.
Autor:
Niezink AG; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands. Electronic address: a.g.h.niezink@umcg.nl., Dollekamp NJ; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Elzinga HJ; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Borger D; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Boer EJ; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Ubbels JF; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Woltman-van Iersel M; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., van der Leest AH; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Beijert M; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Groen HJ; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, The Netherlands., Kraan J; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, The Netherlands., Hiltermann TJ; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, The Netherlands., van der Wekken AJ; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, The Netherlands., van Putten JW; Martini Hospital, Groningen, The Netherlands., Rutgers SR; Scheper Hospital, Emmen, The Netherlands., Pieterman RM; Ommelander Hospital Group, Delfzijl, The Netherlands; Ommelander Hospital Group, Winschoten, The Netherlands., de Hosson SM; Wilhelmina Hospital, Assen, The Netherlands., Roenhorst AW; Refaja Hospital, Stadskanaal, The Netherlands., Langendijk JA; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Widder J; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2015 Apr; Vol. 115 (1), pp. 3-8. Date of Electronic Publication: 2015 Apr 09.